This was a multi-institutional phase II trial of neoadjuvant osimertinib for patients with surgically resectable stage I-IIIA (American Joint Committee on Cancer [AJCC] V7) EGFR-mutated (L858R or exon ...

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Australian Medical Association (AMA) president Mic­hael Gannon yesterday declared doping was “rife” as he slammed the practice. “Doctors are asked to prescribe hypnotics for no other reason ...

Teddi Mellencamp Celebrates Daughter Slate's Elementary School Graduation amid Cancer Treatment: 'Proud of You' The 'Real Housewives' alum shares her three kids with ex Edwin Arroyave. By.

Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Background: Numerous third-line treatment options exist for colorectal ...

Researchers may have come up with an interesting new treatment for cancer by talking to AI. According to a paper published this month, a research team led by the University of Cambridge turned to ...

How ‘Inflammaging’ Drives Cancer—and Points to New Treatments Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like ...

The loss of the Y chromosome in tumour cells is linked to poor outcomes for people with cancer 1, but this genetic alteration might also compromise immune cells that would otherwise fight the ...

Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors account for this.

Immunotherapies in high demand; fueling R&D. The immunotherapy market size was valued at $226.38 billion last year, and it is only projected to grow by almost 12% by 2030, according to Grand View ...

The study, known as Oasis-4, is the fourth successful trial test of Bayer’s drug, called elinzanetant. Detailed data presented at the American Society of Clinical Oncology’s annual meeting Monday ...

Adding niraparib to standard treatment can help slow cancer growth for people with mCSPC with HRR gene alterations. Significance Although a combination of androgen receptor pathway inhibitors has ...